LCAT and Alzheimer disease: To our knowledge, we report for the first time that both the CEC and LCAT activity are overall lower in APOE3E4 carriers compared to APOE3E3 carriers regardless of the AD diagnosis, highlighting the importance of the APOE genotype in the ability to efflux and transport cholesterol.